Stifel Nicolaus analyst Annabel Samimy maintained a Buy rating on MBX Biosciences, Inc. (MBX – Research Report) today. The company’s shares ...
In a report released today, Benjamin Burnett from Stifel Nicolaus maintained a Buy rating on Disc Medicine (IRON – Research Report), with a ...
e.l.f. Beauty (NYSE:ELF – Free Report) had its target price decreased by Stifel Nicolaus from $115.00 to ... from $156.00 to $158.00 and gave the company a “buy” rating in a research report ...
Stifel Nicolaus’ target price would indicate a potential upside of 36.14% from the company’s current price. A number of other equities research analysts have also recently commented on the stock.
Stifel’s broker-dealer clients are served in the United States through Stifel, Nicolaus & Company, Incorporated, including its Eaton Partners and Miller Buckfire business divisions; Keefe ...
Stifel's broker-dealer clients are served in the United States through Stifel, Nicolaus & Company, Incorporated, including its Eaton Partners and Miller Buckfire business divisions; Keefe ...
Stifel’s broker-dealer clients are served in the United States through Stifel, Nicolaus & Company, Incorporated, including its Eaton Partners and Miller Buckfire business divisions; Keefe ...
Stifel is well positioned to capitalize on improving market conditions in 2025 and to achieve our short and long term targets.” Full Year Highlights The Company reported record net revenues of $ ...
Stifel Financial (SF) came out with quarterly earnings of $2.23 per share, beating the Zacks Consensus Estimate of $1.97 per share. This compares to earnings of $1.50 per share a year ago.
Stifel's broker-dealer clients are served in the United States through Stifel, Nicolaus & Company, Incorporated, including its Eaton Partners and Miller Buckfire business divisions; Keefe, Bruyette & ...
(MENAFN- GlobeNewsWire - Nasdaq) ST. LOUIS, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Stifel financial Corp. (NYSE: SF) today reported net revenues of $1.36 billion for the three months ended December 31 ...